Table 2.
Items | Treatments1 |
SEM | P-value | |||
---|---|---|---|---|---|---|
NCO | ANT | GML1 | GML2 | |||
BW, g | ||||||
1 d | 35.53 | 35.49 | 35.46 | 35.23 | 0.08 | 0.506 |
28 d | 472.50b | 512.68a | 521.79a | 508.61a | 6.20 | 0.001 |
56 d | 1,490.00b | 1,540.98a | 1,559.98a | 1,540.23a | 6.17 | 0.001 |
ADG, (g/day) | ||||||
1–28 d | 15.61b | 17.04a | 17.37a | 16.91a | 0.16 | 0.001 |
29–56 d | 36.34 | 36.73 | 37.08 | 36.84 | 0.15 | 0.42 |
1–56 d | 25.97b | 26.88a | 27.22a | 26.88a | 0.11 | 0.001 |
a,bMean with different superscripts in the same row differ significantly (P < 0.05).
Abbreviations: ANT, basal diet supplemented with 30 mg/kg bacitracin; GLM, glycerol monolaurate; GML1, basal diet supplemented with 500 mg/kg α-GML; GML2, basal diet supplemented with 1,000 mg/kg α-GML; NCO, basal diet provided as control.
The mean represent results from 8 replicate cages per treatment.